Literature DB >> 24284809

Obstructive sleep apnea syndrome; a neglected cause of traffic collision among Iranian public transport drivers.

Habibolah Khazaie1, Azad Maroufi.   

Abstract

Entities:  

Mesh:

Year:  2013        PMID: 24284809      PMCID: PMC4009178          DOI: 10.5249/jivr.v6i2.577

Source DB:  PubMed          Journal:  J Inj Violence Res        ISSN: 2008-2053


× No keyword cloud information.
Traffic collision ranks as the second most common cause of mortality among Iranian people.[1] Several studies have reported that Obstructive Sleep Apnea Syndrome (OSAS) increases the risk of car crash. [1,2,3] About 27% of the Iranian population suffers from OSAS.[4] Some studies have revealed that a history of witnessed apnea is the most important predictor of motor vehicle crash.[1] In this report, we wish to present the results of our preliminary findings at the Sleep Disorders Research Center of Kermanshah University of Medical Sciences with regard to this problem among public transport drivers in western Iran. First of all, we screened 170 public transport drivers for objective OSAS using a Berlin Questionnaire. [5] Among these, 50 cases (29.5%) were distinguished as high risk for OSAS. In the next phase of the study, we evaluated these 50 cases using Actigraphy or Polysomnography. Results showed that 85% of them suffered from moderate to severe OSAS (AHI or RDI >15). Nearly all (95%) of them had daily sleepiness. Despite adequate education and advice about the necessity of treatment using CPAP, BiPAP or Auto CPAP; only two patients (4.5%) agreed to use Auto CPAP. Both of them showed poor compliance in their use of Auto CPAP and discontinued the treatment after only a few nights when followed up. These preliminary results seem to indicate that most people with untreated OSAS in our country still continue to work in high-risk jobs, such as driving public transport vehicles. This risks not only their own lives but also those of other road-users and contributes to making Iranian roads among the most dangerous in the world.[6] Future studies must focus on the prevalence of this syndrome among the population in general and among public transport drivers and others doing high-risk jobs in Iran in particular.
  6 in total

1.  Road-traffic-related mortality in Iran: a descriptive study.

Authors:  A Montazeri
Journal:  Public Health       Date:  2004-03       Impact factor: 2.427

2.  The 10-year risk of verified motor vehicle crashes in relation to physiologic sleepiness.

Authors:  Christopher Drake; Timothy Roehrs; Naomi Breslau; Eric Johnson; Catherine Jefferson; Holly Scofield; Thomas Roth
Journal:  Sleep       Date:  2010-06       Impact factor: 5.849

3.  Prevalence of symptoms and risk of obstructive sleep apnea syndrome in the general population.

Authors:  Habibolah Khazaie; Farid Najafi; Leeba Rezaie; Masoud Tahmasian; Amir Ali Sepehry; Felix J F Herth
Journal:  Arch Iran Med       Date:  2011-09       Impact factor: 1.354

Review 4.  A systematic review of screening questionnaires for obstructive sleep apnea.

Authors:  Amir Abrishami; Ali Khajehdehi; Frances Chung
Journal:  Can J Anaesth       Date:  2010-02-09       Impact factor: 5.063

5.  [Obstructive sleep apnea (OSA) syndrome and traffic accidents].

Authors:  Lorena Adriana Bîrleanu; Gianina Rusu; T Mihaescu
Journal:  Rev Med Chir Soc Med Nat Iasi       Date:  2010 Jul-Sep

6.  Impact of sleep deprivation and obstructive sleep apnea syndrome on daytime vigilance and driving performance: a laboratory perspective.

Authors:  F Pizza; S Contardi; S Mondini; F Cirignotta
Journal:  G Ital Med Lav Ergon       Date:  2012 Jul-Sep
  6 in total
  9 in total

Review 1.  Emerging co-morbidities of obstructive sleep apnea: cognition, kidney disease, and cancer.

Authors:  Nadia Gildeh; Panagis Drakatos; Sean Higgins; Ivana Rosenzweig; Brian D Kent
Journal:  J Thorac Dis       Date:  2016-09       Impact factor: 2.895

2.  The Association Between Obstructive Sleep Apnea and Alzheimer's Disease: A Meta-Analysis Perspective.

Authors:  Farnoosh Emamian; Habibolah Khazaie; Masoud Tahmasian; Guy D Leschziner; Mary J Morrell; Ging-Yuek R Hsiung; Ivana Rosenzweig; Amir A Sepehry
Journal:  Front Aging Neurosci       Date:  2016-04-12       Impact factor: 5.750

3.  The importance of obstructive sleep apnea screening in driving license application procedures.

Authors:  Habibolah Khazaie; Mohammad Rasoul Ghadami; Maryam Masoudi
Journal:  J Inj Violence Res       Date:  2016-07-08

Review 4.  The Prevalence of Sleep Apnea in Iran: a Systematic Review and Meta-Analysis.

Authors:  Mandana Sarokhani; Mitra Goli; Shahin Salarvand; Reza Ghanei Gheshlagh
Journal:  Tanaffos       Date:  2019-01

Review 5.  Prevalence Rates and Risk Factors for Primary Open Angle Glaucoma in the Middle East.

Authors:  Rana Torabi; Alon Harris; Brent Siesky; Ryan Zukerman; Francesco Oddone; Sunu Mathew; Ingrida Januleviciene; Alice C Verticchio Vercellin
Journal:  J Ophthalmic Vis Res       Date:  2021-10-25

6.  Sleep Architecture in Patients With Primary Snoring and Obstructive Sleep Apnea.

Authors:  Kaveh Shahveisi; Amir Jalali; Mohammad Raman Moloudi; Shahla Moradi; Azad Maroufi; Habibolah Khazaie
Journal:  Basic Clin Neurosci       Date:  2018 Mar-Apr

7.  Barriers to acceptance and adherence to continuous positive airway pressure therapy in patients with obstructive sleep apnea: a report from Kermanshah province, western Iran.

Authors:  Leeba Rezaie; David Phillips; Habibolah Khazaie
Journal:  Patient Prefer Adherence       Date:  2018-07-20       Impact factor: 2.711

8.  Serum testosterone/cortisol ratio in people with obstructive sleep apnea.

Authors:  Hiwa Mohammadi; Mohammad Rezaei; Amir Sharafkhaneh; Habibolah Khazaie; Mohammad Rasoul Ghadami
Journal:  J Clin Lab Anal       Date:  2019-09-23       Impact factor: 2.352

Review 9.  Structural and functional neural adaptations in obstructive sleep apnea: An activation likelihood estimation meta-analysis.

Authors:  Masoud Tahmasian; Ivana Rosenzweig; Simon B Eickhoff; Amir A Sepehry; Angela R Laird; Peter T Fox; Mary J Morrell; Habibolah Khazaie; Claudia R Eickhoff
Journal:  Neurosci Biobehav Rev       Date:  2016-03-31       Impact factor: 8.989

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.